Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.

about

Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.

Item

http://www.wikidata.org/entity/Q50964118

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@en

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@nl

type

Item

label

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@en

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@nl

prefLabel

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@en

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@nl

P1476

Resveratrol-Mediated Expressio ...... an Improved Cardiac Phenotype.

@en

P2093

Jeffrey S Otis

http://www.w3.org/2001/XMLSchema#string

Russell G Rogers

http://www.w3.org/2001/XMLSchema#string

P2860

Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.

Regulation of cardiac gene expression by KLF15, a repressor of myocardin activity

The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts

Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1

Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor

Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity

Cardiac myocyte gene expression profiling during H2O2-induced apoptosis

Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury

NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

P304

29-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-016-6707-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28064408

http://www.w3.org/2001/XMLSchema#string